These innovations arrive at a pivotal moment when ailing health systems cost more and deliver less. WHOOP is advancing a new ...

Reply, an international group specialised in the development of new business models enabled by Artificial Intelligence and ...

Xsolla, a global leader in video game commerce, is pleased to announce the acquisition of Ludo, a platform designed to drive ...

NPI enables brands and retailers to spot trends early, personalize experiences and accelerate innovation with confidence by translating billions of product data points into structured claims, ...

As demand for virtual ADHD care increases, findings from a new study conducted with ADHD 360, the UK’s largest evidence-based digital service specializing in ADHD diagnosis and treatment, reveal how ...

PPG (NYSE: PPG) today announced that it will invest $380 million to build a new aerospace coatings and sealants manufacturing facility in Shelby, N.C. Construction on the 62-acre site, which will ...

Celonis, the global leader in Process Mining and Process Intelligence, today announced that it has been named a Leader in the Gartner Magic Quadrant for Process Mining Platforms for the third time.

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the first ...

Adtran today announced that eCommunity ™ Fiber is leveraging its fiber access platform to power the City of Morrow’s smart city initiative. This open-access deployment provides high-speed connectivity ...

GC Aesthetics® (GCA), a privately-held medical technology company providing aesthetic and reconstruction solutions for global healthcare markets is pleased to announce the appointment of Mr. Luigi ...

Novotech, a leading global clinical research organization (CRO) and scientific advisory partner, has published a report analyzing recent trends in obesity-related clinical trials. The report shows ...

LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the topline results from the LIGHTSITE IIIB Extension Trial, a ...